Better Health for All

GoodRx's core services have led to significant positive health outcomes, including at least 590,000 fewer ER visits and 336,000 fewer hospitalizations for conditions like COPD, depression, diabetes, and cardiovascular events since 2012.

The company has also improved medication adherence from 39% to nearly 66% for commonly purchased medications, helping users fill at least 184 million prescriptions they otherwise couldn't afford. Users saved an average of 82% on retail prescription prices in the 12 months ending September 30, 2023, and $65 billion since founding, with up to 88% off average commercial insurance copays for brand medications. GoodRx Health, an online tool, provides health information to an average of 11 million people per month. The company supports healthcare workforce diversity through its Students for Healthcare Equity Scholarship, which has awarded $300,000 to students from diverse backgrounds since inception. The scholarship, offering $5,000 renewable for up to 3 years, aims to increase diversity in the healthcare workforce, particularly for Black/African American (7% of workforce vs. 13.6% of population) and Hispanic (1% of workforce vs. 19.1% of population) individuals.

Fair Pay & Worker Respect

The provided articles do not contain any specific, quantitative data or concrete facts regarding GoodRx's performance across any of the Fair Pay & Worker Respect KPIs, including living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage.

All articles explicitly state that no relevant data could be extracted.

Honest & Fair Business

GoodRx incurred a total of $26.5 million in ethics-related regulatory fines within the past three years, comprising a $1.5 million civil penalty in February 2023 and a $25 million settlement for privacy violations.

The company's Code of Business Conduct and Ethics, effective November 29, 2023, includes a policy against retaliation for good-faith reporting and provides a 24/7 anonymous Ethics Hotline. However, the policy does not specify the frequency of training or publicly measure program effectiveness. The company also recast prior period amounts in its Condensed Consolidated Statements of Operations to conform with current period presentation for subscription and pharma manufacturer solutions revenue. GoodRx states its commitment to complying with the U.S. Foreign Corrupt Practices Act and other anti-corruption laws, and that it has not made unlawful payments or received notices concerning violations of Anti-Corruption Laws. However, the policy does not specify training frequency or effectiveness metrics.

Kind to Animals

GoodRx Holdings, Inc. operates a digital platform for prescription drug prices and does not engage in activities directly related to animal welfare, such as manufacturing products, animal testing, or animal agriculture.

The company's core business model is service-oriented, providing information and tools for medication pricing. Therefore, all KPIs related to cruelty-free certification, alternative testing methods, humane operations, wildlife conservation, ethical input substitution, supplier audits for animal welfare, cage-free sourcing, animal testing policies or volume, innovation in animal-free technologies, animal agriculture ethics, and animal-free R&D collaboration are not applicable. While the company's Code of Business Conduct and Ethics mentions general political participation, it does not specify engagement in animal welfare policy.

No War, No Weapons

GoodRx Holdings, Inc.'s core business is focused on providing information and tools for prescription drug pricing and access to affordable medications.

No evidence in the provided articles indicates any revenue derived from arms or defense contracts, nor any exposure to controversial or banned weapons. There is also no mention of ethical red lines related to weapons or any defense-related assets requiring divestment. Therefore, the company's activities do not fall into categories requiring negative scoring for these KPIs.

Planet-Friendly Business

GoodRx Holdings, Inc. does not publicly disclose its carbon emissions, nor does it report any reduction targets or climate commitments.

The company is not participating in any tracked reduction initiatives or disclosure networks. There is no publicly available data regarding its renewable energy usage, water consumption, waste diversion rates, or any environmental compliance violations. Information on climate-related financial disclosures, such as TCFD alignment or climate scenario analysis, is also not provided.

Safe & Smart Tech

GoodRx agreed to pay a $1.5 million penalty for HIPAA violations related to data sharing.

This indicates a failure in compliance with major privacy regulations and constitutes an incident of unauthorized data use.

Zero Waste & Sustainable Products

The provided article discusses GoodRx's services related to prescription medication discounts and healthcare topics.

It explicitly states that it does not contain any data relevant to environmental sustainability or waste management practices for GDRX.US. Therefore, no evidence is available to assess the company against any of the 'Zero Waste & Sustainable Products' KPIs.